OpenURL Connection Search

Select item for more details and to access through your institution.

Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.
Published in:
2020
By:
- Dietrich, Michael;
- Koska, Valeria;
- Hecker, Christina;
- Göttle, Peter;
- Hilla, Alexander M;
- Heskamp, Annemarie;
- Lepka, Klaudia;
- Issberner, Andrea;
- Hallenberger, Angelika;
- Baksmeier, Christine;
- Steckel, Julia;
- Balk, Lisanne;
- Knier, Benjamin;
- Korn, Thomas;
- Havla, Joachim;
- Martínez-Lapiscina, Elena H;
- Solà-Valls, Nuria;
- Manogaran, Praveena;
- Olbert, Elisabeth D;
- Schippling, Sven
Publication type:
journal article
Iron-sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microglia.
Published in:
Glia, 2017, v. 65, n. 9, p. 1521, doi. 10.1002/glia.23178
By:
- Lepka, Klaudia;
- Volbracht, Katrin;
- Bill, Eckhard;
- Schneider, Reiner;
- Rios, Natalia;
- Hildebrandt, Thomas;
- Ingwersen, Jens;
- Prozorovski, Timur;
- Lillig, Christopher Horst;
- van Horssen, Jack;
- Steinman, Lawrence;
- Hartung, Hans‐Peter;
- Radi, Rafael;
- Holmgren, Arne;
- Aktas, Orhan;
- Berndt, Carsten
Publication type:
Article
Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatment.
Published in:
Multiple Sclerosis Journal, 2018, v. 24, n. 13, p. 1776, doi. 10.1177/1352458518771276
By:
- Graf, Jonas;
- Ringelstein, Marius;
- Lepka, Klaudia;
- Schaller, Jörg;
- Quack, Helmut;
- Hartung, Hans-Peter;
- Aktas, Orhan;
- Albrecht, Philipp
Publication type:
Article
Relapse-independent multiple sclerosis progression under natalizumab.
Published in:
Brain Communications, 2021, v. 3, n. 4, p. 1, doi. 10.1093/braincomms/fcab229
By:
- Graf, Jonas;
- Leussink, Verena I.;
- Soncin, Giulia;
- Lepka, Klaudia;
- Meinl, Ingrid;
- Kümpfel, Tania;
- Meuth, Sven G.;
- Hartung, Hans-Peter;
- Havla, Joachim;
- Aktas, Orhan;
- Albrecht, Philipp
Publication type:
Article
Factors associated with headache in intravenous immunoglobulin treatment for neurological diseases.
Published in:
Acta Neurologica Scandinavica, 2019, v. 140, n. 4, p. 290, doi. 10.1111/ane.13144
By:
- Graf, Jonas;
- Ingwersen, Jens;
- Lepka, Klaudia;
- Albrecht, Philipp;
- Hartung, Hans‐Peter;
- Ringelstein, Marius;
- Aktas, Orhan
Publication type:
Article
The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.
Published in:
Acta Neuropathologica, 2019, v. 137, n. 2, p. 239, doi. 10.1007/s00401-018-1929-5
By:
- Walter, Susanne;
- Jumpertz, Thorsten;
- Hüttenrauch, Melanie;
- Ogorek, Isabella;
- Gerber, Hermeto;
- Storck, Steffen E.;
- Zampar, Silvia;
- Dimitrov, Mitko;
- Lehmann, Sandra;
- Lepka, Klaudia;
- Berndt, Carsten;
- Wiltfang, Jens;
- Becker-Pauly, Christoph;
- Beher, Dirk;
- Pietrzik, Claus U.;
- Fraering, Patrick C.;
- Wirths, Oliver;
- Weggen, Sascha
Publication type:
Article

Found: 6

Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.

Iron-sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microglia.

Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatment.

Relapse-independent multiple sclerosis progression under natalizumab.

Factors associated with headache in intravenous immunoglobulin treatment for neurological diseases.

The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.